Literature DB >> 22735528

Cell-intrinsic functional effects of the α-cardiac myosin Arg-403-Gln mutation in familial hypertrophic cardiomyopathy.

Peiying Chuan1, Sivaraj Sivaramakrishnan, Euan A Ashley, James A Spudich.   

Abstract

Human familial hypertrophic cardiomyopathy is the most common Mendelian cardiovascular disease worldwide. Among the most severe presentations of the disease are those in families heterozygous for the mutation R403Q in β-cardiac myosin. Mice heterozygous for this mutation in the α-cardiac myosin isoform display typical familial hypertrophic cardiomyopathy pathology. Here, we study cardiomyocytes from heterozygous 403/+ mice. The effects of the R403Q mutation on force-generating capabilities and dynamics of cardiomyocytes were investigated using a dual carbon nanofiber technique to measure single-cell parameters. We demonstrate the Frank-Starling effect at the single cardiomyocyte level by showing that cell stretch causes an increase in amplitude of contraction. Mutant 403/+ cardiomyocytes exhibit higher end-diastolic and end-systolic stiffness than +/+ cardiomyocytes, whereas active force generation capabilities remain unchanged. Additionally, 403/+ cardiomyocytes show slowed relaxation dynamics. These phenotypes are consistent with increased end-diastolic and end-systolic chamber elastance, as well as diastolic dysfunction seen at the level of the whole heart. Our results show that these functional effects of the R403Q mutation are cell-intrinsic, a property that may be a general phenomenon in familial hypertrophic cardiomyopathy.
Copyright © 2012 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22735528      PMCID: PMC3379014          DOI: 10.1016/j.bpj.2012.04.049

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  57 in total

1.  An alpha-cardiac myosin heavy chain gene mutation impairs contraction and relaxation function of cardiac myocytes.

Authors:  S J Kim; K Iizuka; R A Kelly; Y J Geng; S P Bishop; G Yang; A Kudej; B K McConnell; C E Seidman; J G Seidman; S F Vatner
Journal:  Am J Physiol       Date:  1999-05

2.  Single cell mechanics of rat cardiomyocytes under isometric, unloaded, and physiologically loaded conditions.

Authors:  Satoshi Nishimura; So-ichiro Yasuda; Masayoshi Katoh; Kelly P Yamada; Hiroshi Yamashita; Yasutake Saeki; Kenji Sunagawa; Ryozo Nagai; Toshiaki Hisada; Seiryo Sugiura
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-03-04       Impact factor: 4.733

3.  Comparison of two murine models of familial hypertrophic cardiomyopathy.

Authors:  B K McConnell; D Fatkin; C Semsarian; K A Jones; D Georgakopoulos; C T Maguire; M J Healey; J O Mudd; I P Moskowitz; D A Conner; M Giewat; H Wakimoto; C I Berul; F J Schoen; D A Kass; C E Seidman; J G Seidman
Journal:  Circ Res       Date:  2001-03-02       Impact factor: 17.367

4.  Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.

Authors:  N D Epstein; G M Cohn; F Cyran; L Fananapazir
Journal:  Circulation       Date:  1992-08       Impact factor: 29.690

5.  The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.

Authors:  Christopher Semsarian; Imran Ahmad; Michael Giewat; Dimitrios Georgakopoulos; Joachim P Schmitt; Bradley K McConnell; Steven Reiken; Ulrike Mende; Andrew R Marks; David A Kass; Christine E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

6.  Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy.

Authors:  M J Tyska; E Hayes; M Giewat; C E Seidman; J G Seidman; D M Warshaw
Journal:  Circ Res       Date:  2000-04-14       Impact factor: 17.367

7.  Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium.

Authors:  Bradley M Palmer; David E Fishbaugher; Joachim P Schmitt; Yuan Wang; Norman R Alpert; Christine E Seidman; J G Seidman; Peter VanBuren; David W Maughan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-03-04       Impact factor: 4.733

8.  Transcriptional activation of the cardiac myosin light chain 2 and atrial natriuretic factor genes by protein kinase C in neonatal rat ventricular myocytes.

Authors:  H E Shubeita; E A Martinson; M Van Bilsen; K R Chien; J H Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

9.  PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness.

Authors:  Carlos Hidalgo; Bryan Hudson; Julius Bogomolovas; Yi Zhu; Brian Anderson; Marion Greaser; Siegfried Labeit; Henk Granzier
Journal:  Circ Res       Date:  2009-08-13       Impact factor: 17.367

10.  The R403Q myosin mutation implicated in familial hypertrophic cardiomyopathy causes disorder at the actomyosin interface.

Authors:  Niels Volkmann; Hongjun Lui; Larnele Hazelwood; Kathleen M Trybus; Susan Lowey; Dorit Hanein
Journal:  PLoS One       Date:  2007-11-07       Impact factor: 3.240

View more
  9 in total

Review 1.  Genetics and disease of ventricular muscle.

Authors:  Diane Fatkin; Christine E Seidman; Jonathan G Seidman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

Review 2.  Myofilament Calcium Sensitivity: Role in Regulation of In vivo Cardiac Contraction and Relaxation.

Authors:  Jae-Hoon Chung; Brandon J Biesiadecki; Mark T Ziolo; Jonathan P Davis; Paul M L Janssen
Journal:  Front Physiol       Date:  2016-12-16       Impact factor: 4.566

3.  Extracellular Matrix From Hypertrophic Myocardium Provokes Impaired Twitch Dynamics in Healthy Cardiomyocytes.

Authors:  Lorenzo R Sewanan; Jonas Schwan; Jonathan Kluger; Jinkyu Park; Daniel L Jacoby; Yibing Qyang; Stuart G Campbell
Journal:  JACC Basic Transl Sci       Date:  2019-07-24

4.  A Novel Missense Variant in Actin Binding Domain of MYH7 Is Associated With Left Ventricular Noncompaction.

Authors:  Mahdi Hesaraki; Ugur Bora; Sara Pahlavan; Najmeh Salehi; Seyed Ahmad Mousavi; Maryam Barekat; Seyed Javad Rasouli; Hossein Baharvand; Gunes Ozhan; Mehdi Totonchi
Journal:  Front Cardiovasc Med       Date:  2022-04-08

5.  Hypertrophic cardiomyopathy: translating cellular cross talk into therapeutics.

Authors:  Polakit Teekakirikul; Robert F Padera; J G Seidman; Christine E Seidman
Journal:  J Cell Biol       Date:  2012-10-29       Impact factor: 10.539

Review 6.  Hypertrophic and dilated cardiomyopathy: four decades of basic research on muscle lead to potential therapeutic approaches to these devastating genetic diseases.

Authors:  James A Spudich
Journal:  Biophys J       Date:  2014-03-18       Impact factor: 4.033

Review 7.  The Role of the L-Type Ca2+ Channel in Altered Metabolic Activity in a Murine Model of Hypertrophic Cardiomyopathy.

Authors:  Helena M Viola; Victoria P A Johnstone; Henrietta Cserne Szappanos; Tara R Richman; Tatiana Tsoutsman; Aleksandra Filipovska; Christopher Semsarian; Jonathan G Seidman; Christine E Seidman; Livia C Hool
Journal:  JACC Basic Transl Sci       Date:  2016-02-13

Review 8.  Genetic and Tissue Engineering Approaches to Modeling the Mechanics of Human Heart Failure for Drug Discovery.

Authors:  Michael J Greenberg; Neil J Daily; Ann Wang; Michael K Conway; Tetsuro Wakatsuki
Journal:  Front Cardiovasc Med       Date:  2018-09-19

9.  Haploinsufficiency of mechanistic target of rapamycin ameliorates bag3 cardiomyopathy in adult zebrafish.

Authors:  Yonghe Ding; Alexey V Dvornikov; Xiao Ma; Hong Zhang; Yong Wang; Matthew Lowerison; Rene R Packard; Lei Wang; Jun Chen; Yuji Zhang; Tzung Hsiai; Xueying Lin; Xiaolei Xu
Journal:  Dis Model Mech       Date:  2019-10-01       Impact factor: 5.758

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.